Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar 20;28(9):1540-6.
doi: 10.1200/JCO.2009.25.9739. Epub 2010 Feb 16.

Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study

Christopher G Slatore  1 , Jason W Chien, David H Au, Jessie A Satia, Emily White
Affiliations

Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study

Christopher G Slatore et al. J Clin Oncol. .

Abstract

Purpose: Lung cancer is the leading cause of cancer-related mortality among women. The role of hormone replacement therapy (HRT) in lung cancer development is unclear.

Patients and methods: We evaluated a prospective cohort of 36,588 peri- and postmenopausal women aged 50 to 76 years from Washington State recruited in 2000 to 2002 (Vitamins and Lifestyle [VITAL] Study). Lung cancer cases (n = 344) were identified through the Seattle-Puget Sound Surveillance, Epidemiology, and End Results cancer registry during 6 years of follow-up. Hazard ratios (HRs) associated with use and duration of specific HRT formulations were calculated for total incident lung cancer, specific morphologies, and cancer by stage at diagnosis.

Results: After adjusting for smoking, age, and other potential confounders, there was an increased risk of incident lung cancer associated with increasing duration of estrogen plus progestin (E+P) use (HR = 1.27 for E+P use 1 to 9 years, 95% CI, 0.91 to 1.78; and HR = 1.48 for E+P use > or = 10 years, 95% CI, 1.03 to 2.12; P for trend = .03). There was no association with duration of unopposed estrogen use. Duration of E+P use was associated with an advanced stage at diagnosis (P for trend = .03).

Conclusion: Use of E+P increased the risk of incident lung cancer in a duration-dependent manner, with an approximate 50% increased risk for use of 10 years or longer. These findings may be helpful for informing women of their risk of developing lung cancer and delineating important pathways involved in hormone metabolism and lung cancer.

PubMed Disclaimer

Conflict of interest statement

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

References

    1. Ries LAG, MD, Krapcho M, Mariotto A, et al. Bethesda, MD: National Cancer Institute; 2008. SEER Cancer Statistics Review, 1975-2004, based on November 2007 SEER data submission, posted to the SEER web site. http://seer.cancer.gov/csr/1975_2005/
    1. Anonymous. Washington, DC: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention; 2004. The Health Consequences of Smoking: A Report of the Surgeon General. CDC Publication No. 7829. http://www.cdc.gov/tobacco/sgr/sgr_2004/index.htm.
    1. Gray J, Mao JT, Szabo E, et al. Lung Cancer Chemoprevention: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest. 2007;132:56S–68S. - PubMed
    1. Centers for Disease Control and Prevention. Cigarette smoking among adults: United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57:1221–1226. - PubMed
    1. Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000;321:323–329. - PMC - PubMed

Publication types